BHVN
Legal & General Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-86,684
| Closed | -$13.1M | – | 3488 |
|
|
2022
Q3 | $13.1M | Sell |
86,684
-649
| -0.7% | -$98.1K | 0.01% | 926 |
|
|
2022
Q2 | $12.7M | Buy |
87,333
+32,299
| +59% | +$4.71M | ﹤0.01% | 960 |
|
|
2022
Q1 | $6.53M | Buy |
55,034
+2,721
| +5% | +$323K | ﹤0.01% | 1377 |
|
|
2021
Q4 | $7.21M | Buy |
52,313
+3,415
| +7% | +$471K | ﹤0.01% | 1386 |
|
|
2021
Q3 | $6.79M | Buy |
48,898
+12,031
| +33% | +$1.67M | ﹤0.01% | 1380 |
|
|
2021
Q2 | $3.58M | Buy |
36,867
+3,092
| +9% | +$300K | ﹤0.01% | 1712 |
|
|
2021
Q1 | $2.31M | Buy |
33,775
+222
| +0.7% | +$15.2K | ﹤0.01% | 1919 |
|
|
2020
Q4 | $2.88M | Sell |
33,553
-128
| -0.4% | -$11K | ﹤0.01% | 1740 |
|
|
2020
Q3 | $2.19M | Buy |
33,681
+3,122
| +10% | +$203K | ﹤0.01% | 1728 |
|
|
2020
Q2 | $2.23M | Buy |
30,559
+3,700
| +14% | +$270K | ﹤0.01% | 1685 |
|
|
2020
Q1 | $914K | Sell |
26,859
-4,578
| -15% | -$156K | ﹤0.01% | 1873 |
|
|
2019
Q4 | $1.71M | Buy |
31,437
+922
| +3% | +$50.2K | ﹤0.01% | 1871 |
|
|
2019
Q3 | $1.27M | Buy |
30,515
+14,559
| +91% | +$607K | ﹤0.01% | 1898 |
|
|
2019
Q2 | $698K | Buy |
15,956
+937
| +6% | +$41K | ﹤0.01% | 2071 |
|
|
2019
Q1 | $773K | Buy |
15,019
+9,735
| +184% | +$501K | ﹤0.01% | 2049 |
|
|
2018
Q4 | $196K | Buy |
5,284
+652
| +14% | +$24.2K | ﹤0.01% | 2307 |
|
|
2018
Q3 | $174K | Buy |
4,632
+215
| +5% | +$8.08K | ﹤0.01% | 2367 |
|
|
2018
Q2 | $175K | Sell |
4,417
-1,209
| -21% | -$47.9K | ﹤0.01% | 2330 |
|
|
2018
Q1 | $145K | Buy |
5,626
+2,963
| +111% | +$76.4K | ﹤0.01% | 2377 |
|
|
2017
Q4 | $72K | Sell |
2,663
-484
| -15% | -$13.1K | ﹤0.01% | 2737 |
|
|
2017
Q3 | $119K | Buy |
3,147
+379
| +14% | +$14.3K | ﹤0.01% | 2555 |
|
|
2017
Q2 | $69K | Buy |
+2,768
| New | +$69K | ﹤0.01% | 2803 |
|